ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 37168 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 37168; 2) Community: the network communities that were significantly associated with the response to NSC 37168; 3) Molecule: the relationships between components within communities and NSC 37168; 4) MDR: the compounds that were significantly associated with the NSC 37168.

NSC Compound Enrichment Correlation
NSC 646127 6H-Pyrido[4,3-b]carbazole, 1,2-dihydro-2,5,9,11-tetra- methyl- 0.0454469012959173 -0.049329935
NSC 653864 Null 0.0454469012959173 0.0025639722
NSC 655072 Null 0.0454469012959173 -0.032902064
NSC 671170 Null 0.0454469012959173 0.28068953
NSC 676779 Olean-12-en-28-oic acid, 3-.beta.-[3-O-(.beta.-L-arabinopyranosyl)- 6-methyl-.beta.-D-glucopyranuronosyloxy]-, [2-O-[[4-O-[3-O-(.beta.-L-arabinopyranosyl)- .beta.-D-xylopyranosyl]-3-O-(.beta.-D-xylop 0.0454469012959173 0.28734467
NSC 676914 2-(4-((4-amino-2-methylphenyl)diazenyl)phenylsulfonyl)ethanesulfonoperoxoic acid 0.0454469012959173 0.23636431
NSC 677776 Null 0.0454469012959173 -0.0051273598
NSC 67925 Null 0.0454469012959173 -0.10255073
NSC 681636 Camptothecin Derivative 0.0454469012959173 0.067079475
NSC 682764 Pyrido[3,2-d][1]benzazepin-6-one, 4-(4-chlorophenyl)-2-phenyl- 0.0454469012959173 -0.12967726
Total:84  Current:80    [First] [Prev] [Next] [Last]